Compare ABSI & ROOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABSI | ROOT |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 997.8M | 881.4M |
| IPO Year | 2021 | 2020 |
| Metric | ABSI | ROOT |
|---|---|---|
| Price | $11.60 | $61.55 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $6.96 | ★ $92.40 |
| AVG Volume (30 Days) | ★ 7.8M | 246.2K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 10.64 | ★ 28.96 |
| EPS | N/A | ★ 2.09 |
| Revenue | $4,534,000.00 | ★ $1,517,100,000.00 |
| Revenue This Year | $215.96 | $11.73 |
| Revenue Next Year | $319.10 | $12.80 |
| P/E Ratio | ★ N/A | $28.71 |
| Revenue Growth | N/A | ★ 28.95 |
| 52 Week Low | $2.24 | $40.91 |
| 52 Week High | $12.06 | $134.00 |
| Indicator | ABSI | ROOT |
|---|---|---|
| Relative Strength Index (RSI) | 73.84 | 61.78 |
| Support Level | $2.76 | $50.09 |
| Resistance Level | N/A | $64.17 |
| Average True Range (ATR) | 1.05 | 3.48 |
| MACD | 0.34 | 0.88 |
| Stochastic Oscillator | 91.83 | 95.78 |
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. It generates revenue from the sales of auto insurance policies within the United States.